What AIBMR Life Sciences does

AIBMR Life Sciences, Inc. is a Seattle-headquartered scientific and regulatory consulting firm founded in 1978 by Alexander G. Schauss, Ph.D., FACN, that serves the natural products, dietary supplement, functional food, and cosmetics industries. The firm is one of the longest-tenured specialty consultancies of its kind in North America and operates multiple U.S. offices (Seattle, Bloomington IN, Orange County CA) plus a dedicated Information Services Center in Tucson that houses its nutraceutical research library, an Affiliate Member of the NIH National Library of Medicine network.

The firm's core service portfolio spans GRAS (Generally Recognized As Safe) self-determination studies and FDA GRAS notifications, New Dietary Ingredient (NDI) notifications, GLP-compliant toxicology studies (genotoxicity, acute, subchronic, chronic, and reproduction studies), cosmetic safety testing and MoCRA compliance, exposure estimates, label reviews, claims substantiation, and FTC compliance consulting. Its proprietary assets include the publicly accessible GRAS Self-Determination Inventory Database and the previously described research library. Notable deliverables include the first FDA GRAS 'No Objection' letter for a Bacillus strain (GanedenBC30) and the first OECD-/FDA-/GLP-compliant comprehensive toxicological safety assessment of CBD-rich hemp oil, published in the Journal of Toxicology.

AIBMR operates as a professional services business, selling project-based consulting engagements to nutraceutical, functional food, cosmetic, and dietary supplement companies. Pricing is not publicly disclosed and engagements are scoped per project. Go-to-market is sales-led, combining peer-reviewed publication presence, industry conference activity (SupplySide West, Vitafoods Europe, SOT ToxExpo), trade-press expert commentary in outlets such as Nutritional Outlook and Natural Products Insider, and trade association affiliations (CRN Associate Member, NIH/NLM affiliate). Since 1978, the firm reports it has worked with more than 600 nutraceutical companies in the United States and globally.

Name

AIBMR Life Sciences

Legal name

AIBMR Life Sciences, Inc.

Website

https://aibmr.com

Company type

Private

Founded year

1978

Operating status

Operating

Headcount range

11–50 employees

Short description

AIBMR Life Sciences is a Seattle-based scientific and regulatory consulting firm founded in 1978 that provides GRAS self-determinations, NDI notifications, toxicology studies, and FDA/FTC compliance services to nutraceutical, functional food, cosmetic, and dietary supplement companies.

Ownership category

akta.pro rank

Product category

Regulatory and Scientific Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Food, Feed & Nutraceutical Analytical Testing (HLAGADAN)

akta.pro secondary industry

Supplier Approval, Verification & Food Safety Risk Management (GFSI-aligned) (AFALADAH)

Keywords

• Regulatory consulting services
• GRAS determination studies
• NDI notification consulting
• Toxicology safety studies
• Dietary supplement compliance

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Regulatory & Scientific Consulting Services: AIBMR provides expert consulting services to natural product, nutraceutical, dietary supplement, cosmetic, and functional food companies. Services include GRAS Independent Conclusion studies, FDA GRAS notifications, NDI Notifications, Regulatory Compliance consulting, Toxicology Studies, Cosmetic Testing, Exposure Estimates, and label reviews. Revenue is generated through consulting fees for these specialized scientific and regulatory services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

AIBMR Life Sciences is a scientific and regulatory consulting firm that helps natural product, nutraceutical, dietary supplement, functional food, and cosmetic companies achieve U.S. market compliance. Its core services include GRAS Independent Conclusion (self-determination) studies, FDA GRAS notifications, New Dietary Ingredient (NDI) notifications, GLP-compliant toxicology studies, MoCRA cosmetic testing, exposure estimates, and FDA/FTC regulatory compliance consulting such as label reviews and claims substantiation.

Product overview

AIBMR Life Sciences is a scientific and regulatory consulting firm providing comprehensive services for the natural products, nutraceutical, and dietary supplement industries. Founded in 1978, it is one of the oldest natural product consulting firms in North America. The company offers an integrated suite of regulatory compliance services including GRAS (Generally Recognized As Safe) self-determination studies and FDA GRAS notifications, NDI (New Dietary Ingredient) notifications, toxicology studies, cosmetic testing, exposure estimates, and FDA/FTC regulatory compliance consulting. AIBMR maintains a GRAS Self-Determination Inventory Database to track industry self-determinations. Services are delivered by a team of experts including naturopathic physicians and toxicologists, supporting clients through preclinical and clinical trials management, product pharmacokinetics, and manuscript preparation and publication.

Differentiator

Problem solved

Functional benefit

Products and services

• GRAS (Generally Recognized As Safe) Consulting Services Expert consulting services for GRAS self-determination studies and FDA GRAS notifications, helping dietary supplement, functional food, and ingredient companies establish that their ingredients are generally recognized as safe under FDA regulations.
• NDI (New Dietary Ingredient) Notification Services Consulting and notification services for New Dietary Ingredient (NDI) submissions to FDA, ensuring compliance with dietary supplement regulatory requirements for ingredients not marketed in the U.S. before October 15, 1994.
• Toxicology Studies Comprehensive toxicological safety assessment services including genotoxicity studies, 90-day repeated dose oral toxicity studies, one-year chronic oral toxicity, reproduction toxicity, and other preclinical safety evaluations conducted according to OECD, FDA, and GLP guidelines.
• Cosmetic Testing Services Acute and safety testing services for cosmetic and personal care products to ensure compliance with the Modernization of Cosmetics Regulations Act (MoCRA), including safety substantiation for finished cosmetic products.
• Exposure Estimates Exposure estimate services to evaluate potential consumer exposure levels for dietary ingredients and other substances for regulatory compliance assessments and GRAS/NDI submissions.
• FDA Regulatory Compliance Consulting Expert guidance on FDA and FTC compliance matters including current Good Manufacturing Practices (cGMP) for dietary supplements, label reviews, claims substantiation, and FTC compliance for advertising.

Quantifiable outcome

• GanedenBC30 became the first Bacillus strain to receive FDA GRAS status, enabling its use in food and supplement applications
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Six partnerships are on record, tiered core and minor.

• CV Sciences, Inc.coreStrategic or Co-development Partner · 15 June 2018CV Sciences contracted AIBMR to perform a groundbreaking OECD-, FDA-, GLP-compliant comprehensive toxicological safety assessment of CBD-rich hemp oil. This landmark study was the first of its kind published in the Journal of Toxicology and enabled CV Sciences to advance its PlusCBD brand with rigorous safety substantiation.
• Toxi-Coop, Zrt.coreTechnology or Integration · 15 June 2018AIBMR Life Sciences, in collaboration with laboratory research partner Toxi-Coop, Zrt., authored the landmark CBD-rich hemp oil toxicological safety assessment manuscript published in the Journal of Toxicology. Toxi-Coop serves as AIBMR's GLP-compliant toxicology laboratory research partner for these studies.
• Seipel GroupcoreStrategic or Co-development Partner · 31 January 2018AIBMR co-authored the Urox clinical trial published in BMC Complementary and Alternative Medicine with Seipel Group. The study demonstrated that Seipel Group's patented herbal formula Urox (containing Crataeva nurvala, Equisetum arvense, and Lindera aggregata) improved symptoms of overactive bladder and urinary incontinence. The co-authored research won NutraIngredients-USA's 'Nutrition Research Project of the Year' award.
• Council for Responsible Nutrition (CRN)minorGTM or Marketing Partner · 8 January 2013AIBMR Life Sciences is an Associate Member of CRN, the leading trade association representing dietary supplement manufacturers and ingredient suppliers. CRN, founded in 1973 and based in Washington, D.C., provides a platform for AIBMR to engage with industry stakeholders and demonstrate its expertise to potential clients.
• Ganeden Biotech (now part of Kerry)coreStrategic or Co-development Partner · 6 August 2012AIBMR led the research and regulatory process resulting in Ganeden Biotech receiving an FDA GRAS 'No Objection' letter for GanedenBC30 probiotic — the first Bacillus strain to receive GRAS status. AIBMR scientists (including Dr. John Endres as Chief Scientific Officer) served as lead panel experts for the GRAS self-determination and FDA notification. The partnership involved one-year chronic oral toxicity with combined reproduction toxicity study of Bacillus coagulans, plus multiple immune health studies.
• National Institutes of Health (NIH) / National Library of MedicineminorOthers · 21 October 2008AIBMR Life Sciences was named an Affiliate Member of the National Network of Libraries of Medicine by the Director of the National Library of Medicine at the NIH. This membership recognizes AIBMR's library as a source of high-quality information services and provides extended research capabilities and faster access to scientific literature for AIBMR staff supporting client projects.

Scale indicators3 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Nutrasource Pharmaceutical & Nutraceutical Services: Nutrasource is the most direct peer to AIBMR, formed from the merger of GRAS Associates, Nutra-Health Law, and other regulatory consultancies. Like AIBMR, Nutrasource provides GRAS determinations, NDI notifications, regulatory consulting, and clinical trial support specifically for natural products, nutraceutical, and dietary supplement clients.
• Burdock Group: Burdock Group is a regulatory and scientific consulting firm specializing in GRAS self-determinations, FDA notifications, food safety, and ingredient toxicology for food, beverage, and dietary supplement companies. The firm is closely comparable to AIBMR in service scope, regulatory focus, and customer profile.
• ChromaDex: ChromaDex operates standards-based ingredient reference materials and offers regulatory and safety science services for natural product and dietary supplement manufacturers. Following its acquisition of Spherix Consulting Group, ChromaDex is a direct competitor in GRAS/NDI consulting and natural-product regulatory science.

Broad incumbents

• NSF International: NSF International operates dietary supplement, cosmetic, and personal care certification and testing programs (e.g., NSF/ANSI 173). While significantly broader than AIBMR, NSF is a competitor for the same clients seeking third-party certification and regulatory support for supplements and cosmetics.
• Intertek: Intertek is a global testing, inspection, and certification provider with extensive food, supplement, and cosmetic testing and regulatory services. It serves many of the same enterprise nutraceutical and cosmetic clients AIBMR targets, though at a vastly broader scale and across many other industries.
• Eurofins Scientific: Eurofins is a global laboratory testing services group with significant food, feed, nutraceutical, and cosmetics testing capabilities. It competes with AIBMR for analytical and safety testing work, although at a vastly larger scale and breadth than AIBMR's specialized consulting focus.
• SGS: SGS is a global inspection, verification, testing, and certification company with food, supplement, and cosmetic industry services. It is a broad incumbent competitor for laboratory testing and regulatory compliance work targeting supplement and cosmetic manufacturers.
• UL (Underwriters Laboratories): UL offers testing, inspection, and certification services that span supplements, cosmetics, and personal care products. While much broader in scope than AIBMR, UL competes for the same manufacturer clients seeking validated safety and quality substantiation.

Emerging players

• ConsumerLab.com: ConsumerLab.com independently tests dietary supplements and publishes quality ratings. While not a direct consulting competitor, it operates in the same nutraceutical quality and safety-substantiation ecosystem and influences buyer perception of supplement safety testing providers like AIBMR.
• Charles River Laboratories: Charles River Laboratories is a large CRO with preclinical safety assessment, toxicology, and genotoxicity services used by pharmaceutical and consumer product companies. Its general toxicology capabilities partially overlap with the GLP-compliant studies AIBMR coordinates via its Toxi-Coop partnership, though Charles River is not nutraceutical-specialized.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/aibmrinc
• Facebookfacebook.com/AIBMR-LIFE-SCIENCES-156004154606528

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIBMR Life Sciences